29023885Komaki Y, Yamada A, Komaki F, Sakuraba AAlimentary pharmacology & therapeuticsAntibodies, Monoclonal; InfliximabBiosimilar Pharmaceuticals; Humans; Inflammatory Bowel DiseasesLetter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply. Aliment Pharmacol Ther. 2017 11; 46(9):905-906.Aliment Pharmacol Ther2017-11-01T00:00:002017Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients-authors' reply.prns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAuthorshipvivo:hasSubjectAreahas subject areaInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedInformationResourcelinked information resourcerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptD000911Chemicals & Drugs33713760.622749Antibodies, MonoclonalAuthorship 1127160.3207710.3207711authors10.255has subject areaD006801Living Beings2262862810.130052HumansD015212Disorders1075460.616857Inflammatory Bowel DiseasesD059451Chemicals & Drugs10200.964953Biosimilar PharmaceuticalsD000069285311510.943714Infliximab